Literature DB >> 18334815

Serum lipids and postprandial glucose and insulin levels in hyperlipidemic subjects after consumption of an oat beta-glucan-containing ready meal.

M Biörklund1, J Holm, G Onning.   

Abstract

BACKGROUND/AIMS: To investigate whether a daily intake of a nutrient-balanced ready meal containing 4 g of oat beta-glucans lowers total cholesterol (T-C) and low-density-lipoprotein cholesterol (LDL-C) in hyperlipidemic subjects and to evaluate its effect on postprandial glucose and insulin concentrations.
METHODS: A parallel, placebo-controlled trial was carried out in 43 healthy men and women with elevated serum cholesterol levels. During the 3-week run-in period, all subjects consumed daily a ready-meal soup, low in energy and fat and high in fiber but without oat beta-glucans. Subjects were then randomly assigned for the following 5-week intervention period to either continue consumption of the control soup or an equal soup supplemented with beta-glucan.
RESULTS: Consumption of the beta-glucan-enriched ready meal decreased T-C (0.22 +/- 0.41 mmol/l) and LDL-C (0.16 +/- 0.36 mmol/l), but the reductions were not significantly lower compared with control. After a meal with beta-glucan soup, neither postprandial glucose nor insulin concentrations were significantly different from those after a control soup.
CONCLUSION: A daily dose of 4 g of oat beta-glucans incorporated into a healthy ready meal did not significantly lower T-C and LDL-C compared with an equal ready meal without beta-glucans. Thus, if a food product fulfils general healthy dietary recommendations it may not necessarily be a candidate for supplementation with beta-glucans. 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18334815     DOI: 10.1159/000121281

Source DB:  PubMed          Journal:  Ann Nutr Metab        ISSN: 0250-6807            Impact factor:   3.374


  9 in total

1.  Satiety and energy intake after single and repeated exposure to gel-forming dietary fiber: post-ingestive effects.

Authors:  A J Wanders; M Mars; K J Borgonjen-van den Berg; C de Graaf; E J M Feskens
Journal:  Int J Obes (Lond)       Date:  2013-09-13       Impact factor: 5.095

Review 2.  Tackling metabolic syndrome by functional foods.

Authors:  Muhammad Issa Khan; Faqir Muhammad Anjum; Muhammad Sohaib; Aysha Sameen
Journal:  Rev Endocr Metab Disord       Date:  2013-09       Impact factor: 6.514

Review 3.  Effects of Oat Beta-Glucan Intake on Lipid Profiles in Hypercholesterolemic Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Junhui Yu; Jiayue Xia; Chao Yang; Da Pan; Dengfeng Xu; Guiju Sun; Hui Xia
Journal:  Nutrients       Date:  2022-05-13       Impact factor: 6.706

4.  Oat prevents obesity and abdominal fat distribution, and improves liver function in humans.

Authors:  Hong-Chou Chang; Chien-Ning Huang; Da-Ming Yeh; Shing-Jung Wang; Chiung-Huei Peng; Chau-Jong Wang
Journal:  Plant Foods Hum Nutr       Date:  2013-03       Impact factor: 3.921

Review 5.  Dietary Fiber Intake and Type 2 Diabetes Mellitus: An Umbrella Review of Meta-analyses.

Authors:  Marc P McRae
Journal:  J Chiropr Med       Date:  2018-03-01

6.  Beta glucan: health benefits in obesity and metabolic syndrome.

Authors:  D El Khoury; C Cuda; B L Luhovyy; G H Anderson
Journal:  J Nutr Metab       Date:  2011-12-11

7.  Effects of oat and wheat bread consumption on lipid profile, blood sugar, and endothelial function in hypercholesterolemic patients: A randomized controlled clinical trial.

Authors:  Amir Momenizadeh; Ramin Heidari; Masoumeh Sadeghi; Faezeh Tabesh; Maryam Ekramzadeh; Zahra Haghighatian; Jafar Golshahi; Mehdi Baseri
Journal:  ARYA Atheroscler       Date:  2014-09

Review 8.  Processing of oat: the impact on oat's cholesterol lowering effect.

Authors:  Myriam M-L Grundy; Anthony Fardet; Susan M Tosh; Gillian T Rich; Peter J Wilde
Journal:  Food Funct       Date:  2018-02-12       Impact factor: 5.396

Review 9.  Effect of oat supplementation interventions on cardiovascular disease risk markers: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Erand Llanaj; Gordana M Dejanovic; Hua Kern; Taulant Muka; Ezra Valido; Arjola Bano; Magda Gamba; Lum Kastrati; Beatrice Minder; Stevan Stojic; Trudy Voortman; Pedro Marques-Vidal; Jivko Stoyanov; Brandon Metzger; Marija Glisic
Journal:  Eur J Nutr       Date:  2022-01-03       Impact factor: 4.865

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.